Search

Sergio Coffa

Examiner (ID: 9524, Phone: (571)270-3022 , Office: P/1675 )

Most Active Art Unit
1658
Art Unit(s)
1676, 1658, 1654, 1675
Total Applications
897
Issued Applications
440
Pending Applications
134
Abandoned Applications
351

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9641877 [patent_doc_number] => 20140219988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'RRECOMBINANT HUMAN SAPOSIN B PROTEIN CONTAINING PHOSPHORYLATED GLUCOSE RING AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/118410 [patent_app_country] => US [patent_app_date] => 2011-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10694 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118410 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/118410
RRECOMBINANT HUMAN SAPOSIN B PROTEIN CONTAINING PHOSPHORYLATED GLUCOSE RING AND USE THEREOF Nov 20, 2011 Abandoned
Array ( [id] => 9223528 [patent_doc_number] => 20140018303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => '3-Amino-2-Hydroxy-4-Phenylbutanoyl-Valyl-Isoleucine, Preparation and Use Thereof' [patent_app_type] => utility [patent_app_number] => 14/008195 [patent_app_country] => US [patent_app_date] => 2011-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2057 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008195 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/008195
3-Amino-2-Hydroxy-4-Phenylbutanoyl-Valyl-Isoleucine, Preparation and Use Thereof Nov 15, 2011 Abandoned
Array ( [id] => 9192027 [patent_doc_number] => 20130331343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'Materials Presenting Notch Signaling Molecules To Control Cell Behavior' [patent_app_type] => utility [patent_app_number] => 13/883005 [patent_app_country] => US [patent_app_date] => 2011-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2555 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883005 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/883005
Materials presenting notch signaling molecules to control cell behavior Nov 7, 2011 Issued
Array ( [id] => 9135515 [patent_doc_number] => 20130296230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'METHOD FOR TREATING MALARIA, METHOD FOR KILLING MALARIA PARASITE, AND USE OF THE METHODS' [patent_app_type] => utility [patent_app_number] => 13/881653 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14662 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881653 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/881653
METHOD FOR TREATING MALARIA, METHOD FOR KILLING MALARIA PARASITE, AND USE OF THE METHODS Oct 26, 2011 Abandoned
Array ( [id] => 8173526 [patent_doc_number] => 20120108495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'Method of Inhibiting Smooth Muscle Cell Proliferation by Using Reconstituted HDL' [patent_app_type] => utility [patent_app_number] => 13/281070 [patent_app_country] => US [patent_app_date] => 2011-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 2936 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108495.pdf [firstpage_image] =>[orig_patent_app_number] => 13281070 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/281070
Method of Inhibiting Smooth Muscle Cell Proliferation by Using Reconstituted HDL Oct 24, 2011 Abandoned
Array ( [id] => 11225337 [patent_doc_number] => 09453053 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-27 [patent_title] => 'Short peptides for enhancing muscle function' [patent_app_type] => utility [patent_app_number] => 13/880705 [patent_app_country] => US [patent_app_date] => 2011-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 27385 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880705 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/880705
Short peptides for enhancing muscle function Oct 19, 2011 Issued
Array ( [id] => 10057337 [patent_doc_number] => 09096682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Peptides and uses' [patent_app_type] => utility [patent_app_number] => 13/879422 [patent_app_country] => US [patent_app_date] => 2011-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 10 [patent_no_of_words] => 29215 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879422 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/879422
Peptides and uses Oct 16, 2011 Issued
Array ( [id] => 10579806 [patent_doc_number] => 09301917 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-05 [patent_title] => 'Sustained-release pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 13/824598 [patent_app_country] => US [patent_app_date] => 2011-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 13418 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13824598 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/824598
Sustained-release pharmaceutical composition Oct 13, 2011 Issued
Array ( [id] => 9964225 [patent_doc_number] => 09011833 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-21 [patent_title] => 'Vitamin E formulations of sulfamide NS3 inhibitors' [patent_app_type] => utility [patent_app_number] => 13/825636 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 45441 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825636 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/825636
Vitamin E formulations of sulfamide NS3 inhibitors Oct 6, 2011 Issued
Array ( [id] => 8056033 [patent_doc_number] => 20120077748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Materials and Methods for Improving Gastrointestinal Function' [patent_app_type] => utility [patent_app_number] => 13/245430 [patent_app_country] => US [patent_app_date] => 2011-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 24206 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077748.pdf [firstpage_image] =>[orig_patent_app_number] => 13245430 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/245430
Materials and methods for improving gastrointestinal function Sep 25, 2011 Issued
Array ( [id] => 8160097 [patent_doc_number] => 20120101030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'Caspofungin Composition' [patent_app_type] => utility [patent_app_number] => 13/237193 [patent_app_country] => US [patent_app_date] => 2011-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4091 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101030.pdf [firstpage_image] =>[orig_patent_app_number] => 13237193 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/237193
Caspofungin Composition Sep 19, 2011 Abandoned
Array ( [id] => 8140703 [patent_doc_number] => 20120094897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION' [patent_app_type] => utility [patent_app_number] => 13/232815 [patent_app_country] => US [patent_app_date] => 2011-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29501 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094897.pdf [firstpage_image] =>[orig_patent_app_number] => 13232815 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/232815
NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION Sep 13, 2011 Abandoned
Array ( [id] => 7818516 [patent_doc_number] => 20120065136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'RECOMBINANT FACTOR VIII HAVING ENHANCED STABILITY FOLLOWING MUTATION AT THE A1-C2 DOMAIN INTERFACE' [patent_app_type] => utility [patent_app_number] => 13/231948 [patent_app_country] => US [patent_app_date] => 2011-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22163 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065136.pdf [firstpage_image] =>[orig_patent_app_number] => 13231948 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/231948
Recombinant factor VIII having enhanced stability following mutation at the A1-C2 domain interface Sep 12, 2011 Issued
Array ( [id] => 7818517 [patent_doc_number] => 20120065137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'THERAPEUTICS FOR TRAUMA INDUCED FACTOR V CONSUMPTIVE COAGULOPATHY' [patent_app_type] => utility [patent_app_number] => 13/225089 [patent_app_country] => US [patent_app_date] => 2011-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12169 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065137.pdf [firstpage_image] =>[orig_patent_app_number] => 13225089 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/225089
THERAPEUTICS FOR TRAUMA INDUCED FACTOR V CONSUMPTIVE COAGULOPATHY Sep 1, 2011 Abandoned
Array ( [id] => 7791024 [patent_doc_number] => 20120052580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'PEPTIDE-MODIFIED SURFACES FOR CELL CULTURE' [patent_app_type] => utility [patent_app_number] => 13/216621 [patent_app_country] => US [patent_app_date] => 2011-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17791 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20120052580.pdf [firstpage_image] =>[orig_patent_app_number] => 13216621 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/216621
PEPTIDE-MODIFIED SURFACES FOR CELL CULTURE Aug 23, 2011 Abandoned
Array ( [id] => 8927944 [patent_doc_number] => 20130183704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'Labeling Agent and Methods for Simultaneous Sequencing and Quantification of Multiple Peptides and Proteins Using the Same' [patent_app_type] => utility [patent_app_number] => 13/818489 [patent_app_country] => US [patent_app_date] => 2011-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 22894 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13818489 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/818489
Labeling agent and methods for simultaneous sequencing and quantification of multiple peptides and proteins using the same Aug 22, 2011 Issued
Array ( [id] => 9777678 [patent_doc_number] => 08852882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Biosensors and their use' [patent_app_type] => utility [patent_app_number] => 13/817743 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9580 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817743 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/817743
Biosensors and their use Aug 15, 2011 Issued
Array ( [id] => 8977313 [patent_doc_number] => 20130210743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'PEPTIDOMIMETIC MACROCYCLES' [patent_app_type] => utility [patent_app_number] => 13/816880 [patent_app_country] => US [patent_app_date] => 2011-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 31186 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816880 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/816880
Peptidomimetic macrocycles Aug 12, 2011 Issued
Array ( [id] => 8792864 [patent_doc_number] => 20130109833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'CYCLIC PEPTIDE COMPOUND OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF AND METHOD FOR PRODUCING SAME' [patent_app_type] => utility [patent_app_number] => 13/808772 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13795 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808772 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/808772
Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same Jul 5, 2011 Issued
Array ( [id] => 8779600 [patent_doc_number] => 20130101575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'LACTOFERRIN SEQENCES, COMPOSITIONS AND METHODS FOR CORNEAL WOUND TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/806247 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12005 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806247 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/806247
LACTOFERRIN SEQENCES, COMPOSITIONS AND METHODS FOR CORNEAL WOUND TREATMENT Jun 30, 2011 Abandoned
Menu